25608 930 Tissue Tek Oct Compound

Tissue-Tek

abx082403-118ml 118 ml
EUR 276

Human IgG antibody Laboratories manufactures the 25608 930 tissue tek oct compound reagents distributed by Genprice. The 25608 930 Tissue Tek Oct Compound reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tissue tek compound. Other 25608 products are available in stock. Specificity: 25608 Category: 930 Group: Tissue Tek

OSI-930

each
EUR 810

OSI-930

each
EUR 248.4

OSI-930

100 mg
EUR 560
Description: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck

OSI-930

25 mg
EUR 256
Description: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck

OSI-930

5 mg
EUR 84
Description: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck

OSI-930

10 mM (in 1mL DMSO)
EUR 120
Description: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck

CC-930

10 mg
EUR 390
Description: JNK inhibitor,potent and selective

Tissue Tek information

Compound 112254

GL3740-10MG 10 mg
EUR 199.2

Compound 112254

GL3740-50 50
EUR 440.4

Compound 112254

GL3740-50MG 50 mg
EUR 550.8

Compound 3344

MBS5786197-10mg 10(mg
EUR 465

Compound 3344

MBS5786197-1mg 1(mg
EUR 215

Compound 3344

MBS5786197-5mg 5(mg
EUR 330

Compound 401

1657-5 each
EUR 285.6

Compound 401

407407 25.0mg
EUR 250

Compound 401

B7337-10 10 mg
EUR 192
Description: DNA-PK and mTOR inhibitor

Compound 401

B7337-100 100mg
EUR 1191
Description: DNA-PK and mTOR inhibitor

Compound 401

B7337-25 25 mg
EUR 529.2

Compound 401

B7337-5 5 mg
EUR 131
Description: DNA-PK and mTOR inhibitor

Compound 401

B7337-50 50mg
EUR 674
Description: DNA-PK and mTOR inhibitor

Compound 401

T3586-10mg 10mg Ask for price
Description: Compound 401

Compound 401

T3586-1g 1g Ask for price
Description: Compound 401

Compound 401

T3586-1mg 1mg Ask for price
Description: Compound 401

Compound 401

T3586-50mg 50mg Ask for price
Description: Compound 401
Scroll to Top